CTOs on the Move

Titan Medical Incorporated

www.titanmedicalinc.com

 
Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, and listed on the Toronto Stock Exchange (TMD) and on NASDAQ in the United States (TMDI). Titan is focused on the design, development and commercialization of novel advanced robotic surgical technologies such as SPORT(TM) Surgical System. Titan`s SPORT Surgical System is a versatile single incision advanced robotic platform that features state-of the-art multi-articulated instruments with unique replaceable tips, 3D visualization on High Definition flat-screen monitor, highly ergonomic open workstation with natural surgeon interface and a single low-profile patient cart for ease of set up that enables broad applications ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Funding

Titan Medical Incorporated raised $25M on 03/22/2019
Titan Medical Incorporated raised $35M on 08/30/2019

Similar Companies

O'Hara Technologies

O'Hara Technologies Inc. is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carlsmed

Carlsmed is transforming medicine by personalizing complex spine surgery to improve patient outcomes.

Oetiker Inc

Oetiker Inc is a Marlette, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

Medron International

Medron International is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.